Redleaf Biologics
Redleaf Biologics, headquartered in the United States, is a pioneering company in the biotechnology industry, specialising in the development of innovative biologics. Founded in 2018, Redleaf has quickly established itself as a leader in the field, focusing on advanced therapeutic solutions that harness the power of nature. The company’s core offerings include a range of biologic products designed to address unmet medical needs, with a commitment to sustainability and efficacy. Redleaf Biologics is recognised for its unique approach to product development, integrating cutting-edge research with environmentally responsible practices. With a strong market position and notable achievements in the biotechnology sector, Redleaf continues to push the boundaries of science, aiming to improve patient outcomes and contribute to the future of healthcare.
DitchCarbon Score
How does Redleaf Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Redleaf Biologics's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Redleaf Biologics's reported carbon emissions
Redleaf Biologics, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete emissions figures or defined reduction strategies, it is challenging to assess their current impact on climate change or their commitment to sustainability. However, the absence of data may indicate an opportunity for the company to enhance transparency and set measurable goals in line with industry standards. As the focus on climate action intensifies, it is crucial for organisations like Redleaf Biologics to establish clear emissions baselines and reduction commitments to contribute effectively to global climate efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Redleaf Biologics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
